Publications by authors named "J A De Juan"

Background: Ferroptosis plays an important role in the development of diabetic nephropathy (DN). However, its specific regulatory mechanisms remain unclear.

Methods: MPC5 cells were cultured in high glucose (HG) medium to stimulate the HG environment in vitro.

View Article and Find Full Text PDF

Nanoparticles of neodymium oxide (NPs-NdO) can induce respiratory-related diseases, including lung tissue injury when entering the organism through the respiratory tract. However, it is currently unclear whether they can induce epithelial-mesenchymal transition (EMT) in lung tissue and the related mechanisms. In this study, we investigated the function of circ_009773 in the process of EMT induced by NPs-NdO in lung tissue from in vivo as well as in vitro experiments.

View Article and Find Full Text PDF

The iliopsoas muscle plays an essential role in lumbopelvic and hip anterior stability, which is particularly important in the presence of limited osseous acetabular coverage anteriorly as in hip dysplasia and/or hip micro-instability. The purpose of this systematic review is to (1) describe iliopsoas activation levels during common rehabilitation exercises and (2) provide an evidence-based exercise progression for strengthening the iliopsoas based on electromyography (EMG) studies. In total, 109 healthy adult participants ranging from ages 20 to 40 were included in nine studies.

View Article and Find Full Text PDF

Heavy metal contamination of water sources has long been a silent yet potent threat, endangering environmental and human health. Conventional wastewater treatments are costly due to high infrastructure expenses, energy consumption, and chemical usage. These treatments lead to secondary environmental pollution, such as producing toxic sludge, greenhouse gaseous emissions, and residual pollutants discharges.

View Article and Find Full Text PDF
Article Synopsis
  • Dual immune checkpoint blockade (ICB) using CTLA4 and PD-(L)1 inhibitors shows improved anti-tumor effectiveness and immune toxicity compared to PD-(L)1 inhibitors alone in advanced non-small-cell lung cancer (NSCLC) patients.
  • Patients with mutations in STK11 and/or KEAP1 genes benefit more from the combination treatment compared to those receiving only PD-(L)1 inhibitors, as shown in the POSEIDON trial.
  • The loss of KEAP1 serves as a strong predictor for the success of dual ICB, as it leads to a more favorable outcome by changing the tumor's immune environment to better engage CD4 and CD8 T cells for anti-tumor activity. *
View Article and Find Full Text PDF